Intermolecular Revenue, Profits - IMI Annual Income Statement

Add to My Stocks
$1.35 $0.04 (3.05%) IMI stock closing price Aug 15, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Intermolecular stock price alone is not sufficient. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for IMI which shows a YOY revenue decline of -21.34% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Intermolecular assets and Intermolecular free cash flow, Intermolecular profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $-10.4M and the 2017 revenue is $37.2M.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Intermolecular Revenues or Net Sales
37.2M47.29M45.32M47.69M67.4M66.82M53.83M42.67M26.91M23.12M
Cost Of Goods Sold (COGS)12.1M15.83M19.3M24.65M32.48M28.4M25.46M20.92M13.01M12.62M
Intermolecular Gross Profit
25.09M31.46M26.01M23.04M34.92M38.42M28.36M21.74M13.89M10.5M
Research & Development Expense21.53M28.12M28.57M24.32M24.5M21.83M19.26M13.91M10.98M11.84M
Selling General & Admin Expense14.56M19.21M18.16M19.76M18.44M16.3M12.81M9.83M8.07M8.14M
Income Before Depreciation Depletion Amortization-11M-15.86M-20.72M-21.04M-8.02M--3.71M-2M-5.16M-9.49M
Depreciation Depletion Amortization----------
Non Operating Income---0.01M-0.02M--0.98M-26.25M--0.06M-
Interest Expense----------
Intermolecular Pretax Income
-10.4M-15.43M-21M-21.75M-8.8M-0.7M-29.97M-1.75M-5.23M-9.31M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-10.4M-15.43M-21.01M-21.76M-8.81M-0.75M-30.01M-1.77M-5.25M-9.5M
Extraordinary Items & Discontinued Operations----------
Intermolecular Profit/ Loss (Net Income)
-10.4M-15.43M-21.01M-21.76M-8.81M-0.75M-30.01M-1.77M-5.25M-9.5M
Average Shares used to compute Diluted EPS49.55M49.4M48.16M46.72M44.96M42.97M9.7M5.57M--
Average Shares used to compute Basic EPS49.55M49.4M48.16M46.72M44.96M42.97M9.7M5.57M--
Income Before Nonrecurring Items-10.4M-15.44M-20.4M-20.4M-8.82M-0.76M5.06M-1.72M--
Income from Nonrecurring Items----1.36M---35.08M-0.06M--
Intermolecular Earnings Per Share Basic Net
-0.21-0.31-0.42-0.47-0.20-0.02-3.99-2.86--
Intermolecular Earnings Per Share Diluted Net
-0.21-0.31-0.42-0.47-0.20-0.02-3.99-2.86--
EPS Diluted Before Nonrecurring Items-0.21-0.31-0.42-0.44-0.20-0.02-0.37-2.85--
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

It is very helpful to read a report on Intermolecular stock analysis. An investor must check the following items in an income statement:

  • Topline: A growing topline, as seen from the Intermolecular revenue chart, as isn't the case with Intermolecular indicates a sagging business. One needs to compare the YoY topline or sales growth of IMI stock with its peers like SPA stock and ELRNF stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: Most businesses like Intermolecular try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The IMI financials along with Intermolecular historical stock prices provide a lot of details about the firm.

Intermolecular Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
1.68
Operating Margin
2.9
Net Profit Margin
5.1
Dividend Yield
0%